Increased risk of second lung cancer in Hodgkin's lymphoma survivors: a meta-analysis (Q38051051)

27 August 2017

0 references

Increased risk of second lung cancer in Hodgkin's lymphoma survivors: a meta-analysis (English)

1 reference

27 August 2017

1 reference

Khaled M Abouelkhair

3

0 references

author name string

Ezzeldin M Ibrahim

1

1 reference

27 August 2017

Ghieth A Kazkaz

2

1 reference

27 August 2017

Mubarak M Al-Mansour

4

1 reference

27 August 2017

Turki M Al-Fayea

5

1 reference

27 August 2017

Meteb Al-Foheidi

6

1 reference

27 August 2017

Ali M Bayer

7

1 reference

27 August 2017

Osama A Elmasri

8

1 reference

27 August 2017

publication date

6 October 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

191

1 reference

27 August 2017

issue

1

1 reference

27 August 2017

page(s)

117-134

1 reference

Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Hodgkin's lymphoma therapy: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Treatment of Hodgkin lymphoma: the past, present, and future.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Letter: second malignancies complicating Hodgkin's disease in remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

State-of-the-art Issues in Hodgkin’s Lymphoma Survivorship

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Risk of second breast cancer in female Hodgkin's lymphoma survivors: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

STrengthening the Reporting of OBservational studies in Epidemiology--Molecular Epidemiology (STROBE-ME): an extension of the STROBE Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Meta-analysis of mortality and cancer incidence among workers in the synthetic rubber-producing industry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Review: a gentle introduction to imputation of missing values

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Second primary malignancy after Hodgkin's disease, ovarian cancer and cancer of the testis: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Second cancer risk following Hodgkin's disease: a 20-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Second malignancies after Hodgkin's disease: the Munich experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

The risk of second malignant tumors and its consequences for the overall survival of Hodgkin's disease patients and for the choice of their treatment at presentation: analysis of a series of 1524 cases consecutively treated at the Florence Universit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Second malignancies after treatment for Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

21 January 2018

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Cigarette smoking and lung cancer trends. A light at the end of the tunnel?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Radiation and cancer risk in atomic-bomb survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Lung cancer following Hodgkin's disease: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Childhood cancer survivors' knowledge about their past diagnosis and treatment: Childhood Cancer Survivor Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Predictors of smoking initiation and cessation among childhood cancer survivors: a report from the childhood cancer survivor study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Transition of care for young adult survivors of childhood and adolescent cancer: rationale and approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Reduced lung-cancer mortality with low-dose computed tomographic screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Late effects in the era of modern therapy for Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Second Malignant Neoplasms Among Long-Term Survivors of Hodgkin’s Disease: A Population-Based Evaluation Over 25 Years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-012-9418-4

Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer

21 January 2018

1 reference

12 December 2020

Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation

1 reference

12 December 2020

Cancer mortality after multiple fluoroscopic examinations of the chest.

1 reference

12 December 2020

Solid tumors in patients treated for Hodgkin's disease: a report from the German Hodgkin Lymphoma Study Group

1 reference

12 December 2020

Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study

1 reference

12 December 2020

Involved-node radiotherapy and modern radiation treatment techniques in patients with Hodgkin lymphoma

1 reference

12 December 2020

Lung cancer in Hodgkin's disease: association with previous radiotherapy

1 reference

12 December 2020

Hodgkin's disease: complications of therapy and excess mortality

1 reference

12 December 2020

Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials

1 reference

12 December 2020

Risk of second cancers after treatment for Hodgkin's disease

1 reference

12 December 2020

Long-term risk of second malignancy after treatment of Hodgkin's disease: the influence of treatment, age and follow-up time

1 reference

12 December 2020

Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence

1 reference

12 December 2020

Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors

1 reference

12 December 2020

Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease

1 reference

12 December 2020

10.1007/S00408-012-9418-4

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1026228500

0 references

1 reference